120 related articles for article (PubMed ID: 32198837)
1. Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
Chandrasekhar J; Kerkmeijer LS; Kalkman DN; Sartori S; Aquino MB; Woudstra P; Beijk MA; Tijssen JG; Koch KT; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iñiguez A; Coufal Z; Khashaba A; Munawar M; Gerber RT; Yan BP; Lee M; Baber U; Dangas GD; Colombo A; de Winter RJ; Mehran R;
Catheter Cardiovasc Interv; 2021 Apr; 97(5):797-804. PubMed ID: 32198837
[TBL] [Abstract][Full Text] [Related]
2. 1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration.
Chandrasekhar J; Zeebregts D; Kalkman DN; Sartori S; Roumeliotis A; Aquino MB; de Wilde P; de Winter VC; Baber U; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Lee M; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; de Winter RJ;
Cardiovasc Revasc Med; 2020 Dec; 21(12):1542-1547. PubMed ID: 32507695
[TBL] [Abstract][Full Text] [Related]
3. 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration.
Chandrasekhar J; Kalkman DN; Aquino MB; Sartori S; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iñiguez A; Coufal Z; Khashaba A; Schee A; Munawar M; Gerber RT; Yan BP; Tejedor P; Kala P; Liew HB; Lee M; Baber U; Vogel B; Dangas GD; Colombo A; de Winter RJ; Mehran R; ;
Int J Cardiol; 2020 May; 307():17-23. PubMed ID: 32111358
[TBL] [Abstract][Full Text] [Related]
4. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.
de Winter RJ; Chandrasekhar J; Kalkman DN; Aquino MB; Woudstra P; Beijk MA; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; ;
JACC Cardiovasc Interv; 2018 Oct; 11(19):1969-1978. PubMed ID: 30286855
[TBL] [Abstract][Full Text] [Related]
5. One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
Chandrasekhar J; de Winter VC; Kalkman DN; Sartori S; Chandiramani R; Aquino MB; de Wilde P; Zeebregts D; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Coufal Z; Lee M; Tijssen JG; Koch KT; Baber U; Dangas GD; Colombo A; de Winter RJ; Mehran R;
Cardiovasc Drugs Ther; 2021 Apr; 35(2):309-320. PubMed ID: 33515411
[TBL] [Abstract][Full Text] [Related]
6. 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
Chandrasekhar J; Kok MM; Kalkman DN; Aquino MB; Zocca P; Woudstra P; Beijk MA; Kerkmeijer LS; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Pocock S; von Birgelen C; Mehran R; de Winter RJ;
JACC Cardiovasc Interv; 2020 Apr; 13(7):820-830. PubMed ID: 32273094
[TBL] [Abstract][Full Text] [Related]
7. 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
Woudstra P; Kalkman DN; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2016 Jun; 9(11):1127-34. PubMed ID: 27209254
[TBL] [Abstract][Full Text] [Related]
8. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.
Nardin M; Pivato CA; Cao D; Sartori S; Zhang Z; Vogel B; Nicolas J; Chiarito M; Qiu H; Chandrasekhar J; Spirito A; Abizaid A; Christiansen EH; Colombo A; de Winter RJ; Haude M; Jakobsen L; Jensen LO; Krucoff MW; Landmesser U; Saito S; Suryapranata H; De Luca G; Dangas G; Mehran R
Int J Cardiol; 2023 Jan; 370():149-155. PubMed ID: 36270496
[TBL] [Abstract][Full Text] [Related]
9. One-year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration.
Chandrasekhar J; Kalkman DN; Sartori S; Baber U; Blum M; Aquino MB; Woudstra P; Beijk MA; Tijssen JG; Koch KT; Dangas GD; Colombo A; de Winter RJ; Mehran R;
Catheter Cardiovasc Interv; 2020 Sep; ():. PubMed ID: 32964556
[TBL] [Abstract][Full Text] [Related]
10. Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry).
Chandrasekhar J; Sartori S; Aquino MB; Baber U; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Coufal Z; Khashaba A; Schee A; Munawar M; Gerber RT; Yan BP; Tejedor P; Kala P; Liew HB; Lee M; Kalkman DN; Dangas GD; de Winter RJ; Colombo A; Mehran R;
Am J Cardiol; 2020 Jul; 127():1-8. PubMed ID: 32418717
[TBL] [Abstract][Full Text] [Related]
11. Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.
Kalkman DN; Kerkmeijer LS; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; van 't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2019 Sep; 94(3):342-347. PubMed ID: 30565371
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.
Colombo A; Chandrasekhar J; Aquino M; Ong TK; Sartori S; Baber U; Lee M; Iniguez A; Hajek P; Borisov B; Atzev B; Den Heijer P; Coufal Z; Hudec M; Mates M; Snyder C; Moalem K; Morrell D; Elmore F; Rowland S; Mehran R;
Int J Cardiol; 2019 May; 283():67-72. PubMed ID: 30826192
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry.
Kerkmeijer LS; Kalkman DN; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; Van't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Cardiovasc Revasc Med; 2020 May; 21(5):567-570. PubMed ID: 31662276
[TBL] [Abstract][Full Text] [Related]
14. Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
Kerkmeijer LSM; Chandrasekhar J; Kalkman DN; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; van 't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2021 Sep; 98(3):503-510. PubMed ID: 33029937
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.
Kalkman DN; Woudstra P; Lu H; Menown IBA; den Heijer P; Suryapranata H; Iñiguez A; Arkenbout KE; Van't Hof AWJ; Muller P; Erglis A; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2017 Aug; 90(2):E31-E37. PubMed ID: 28145609
[TBL] [Abstract][Full Text] [Related]
16. Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stent.
Kalkman DN; Woudstra P; Menown IBA; Tijssen JG; Beijk MAM; de Winter RJ;
Cardiovasc Revasc Med; 2018; 19(3 Pt B):373-375. PubMed ID: 29277288
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Stent Versus Standard Drug-Eluting Coronary Stents: A Meta-Analysis.
Ndunda P; Vindhyal MR; Muutu T; Fanari Z
Cardiovasc Revasc Med; 2020 Feb; 21(2):213-221. PubMed ID: 31147259
[TBL] [Abstract][Full Text] [Related]
19. [Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 5-year results of the TARGET Ⅱ trial].
Xu LJ; Gao Z; Song Y; Wang HH; Xu JJ; Gao LJ; Zhang Y; Song L; Zhao XY; Chen J; Yuan JQ; Qiao SB; Yang YJ; Xu B; Gao RL;
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jul; 46(7):523-528. PubMed ID: 30032542
[No Abstract] [Full Text] [Related]
20. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
